• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发于Thr60Ala转甲状腺素蛋白淀粉样变性的柔脑膜疾病:病例报告及文献复习

Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature.

作者信息

Carberry Nathan, Yu Sun, Fayerman Raisy N, Dugue Rachelle, Miller Michael, Tanji Kurenai, Goyal Tarini, Canoll Peter, Brannagan Thomas H

机构信息

Department of Neurology, Neuromuscular Division, University of Miami Miller School of Medicine, Miami, FL, USA.

Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Neurohospitalist. 2023 Jan;13(1):90-95. doi: 10.1177/19418744221127849. Epub 2022 Oct 9.

DOI:10.1177/19418744221127849
PMID:36531853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9755614/
Abstract

A 31-year-old woman with transthyretin (TTR) amyloidosis secondary to a Thr60Ala mutation developed recurrent stroke-like episodes with fluctuating mental status. Evaluation for stroke and seizures was unrevealing. She was found to have leptomeningeal contrast enhancement on magnetic resonance imaging, which was confirmed to be CNS TTR amyloidosis on histopathology following brain and dura biopsy. While leptomeningeal disease has rarely been known to be associated with TTR amyloidosis, this is the first documented case of leptomeningeal disease secondary to a Thr60Ala mutation in the TTR gene. A literature review of TTR amyloidosis is presented with special focus on the treatment of leptomeningeal TTR amyloidosis.

摘要

一名31岁患有继发于苏氨酸60丙氨酸(Thr60Ala)突变的转甲状腺素蛋白(TTR)淀粉样变性的女性出现反复的类似中风发作,伴有精神状态波动。对中风和癫痫的评估未发现异常。她在磁共振成像上显示软脑膜对比增强,经脑和硬脑膜活检后的组织病理学证实为中枢神经系统TTR淀粉样变性。虽然软脑膜疾病很少被认为与TTR淀粉样变性有关,但这是第一例记录在案的继发于TTR基因中Thr60Ala突变的软脑膜疾病病例。本文对TTR淀粉样变性进行了文献综述,特别关注软脑膜TTR淀粉样变性的治疗。

相似文献

1
Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature.继发于Thr60Ala转甲状腺素蛋白淀粉样变性的柔脑膜疾病:病例报告及文献复习
Neurohospitalist. 2023 Jan;13(1):90-95. doi: 10.1177/19418744221127849. Epub 2022 Oct 9.
2
A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.一种与柔脑膜淀粉样变性相关的新型甲状腺素转运蛋白第49位苏氨酸突变为脯氨酸的基因突变。
J Neurol Sci. 2008 Sep 15;272(1-2):186-90. doi: 10.1016/j.jns.2008.05.014. Epub 2008 Jun 24.
3
TTR associated leptomeningeal amyloidosis in a Sri Lankan patient.斯里兰卡患者伴 TTR 相关硬脑膜血管淀粉样变性。
J Neurol Sci. 2024 Nov 15;466:123273. doi: 10.1016/j.jns.2024.123273. Epub 2024 Oct 15.
4
Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.当前对转甲状腺素蛋白突变相关脑脊髓液淀粉样变性的综述。
Neurologist. 2021 Sep 7;26(5):189-195. doi: 10.1097/NRL.0000000000000337.
5
Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation.一名年轻的非裔加勒比女性因Thr60Ala突变导致甲状腺素运载蛋白淀粉样变性病的早发情况。
JACC Case Rep. 2020 Nov 4;2(13):2063-2067. doi: 10.1016/j.jaccas.2020.08.030. eCollection 2020 Nov.
6
Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.继发于罕见的转甲状腺素蛋白c.381T>G(p.Ile127Met)突变的眼软脑膜淀粉样变性
World Neurosurg. 2018 Mar;111:190-193. doi: 10.1016/j.wneu.2017.12.096. Epub 2017 Dec 23.
7
Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.一名转甲状腺素蛋白基因存在TTR Val30Gly突变的患者发生眼软脑膜淀粉样变性。
Ophthalmology. 2007 Nov;114(11):e33-7. doi: 10.1016/j.ophtha.2007.07.007.
8
Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.伴有转甲状腺素蛋白变体Asp18Gly的家族性软脑膜淀粉样变性,表现为反复蛛网膜下腔出血伴表面铁沉积症。
J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1463-6. doi: 10.1136/jnnp.2003.029942.
9
[Case of hereditary Y69H (p.Y89H) transthyretin variant leptomeningeal amyloidosis presenting with drop attacks and recurrent transient language disorder].[遗传性Y69H(p.Y89H)转甲状腺素蛋白变异型软脑膜淀粉样变性伴猝倒发作和复发性短暂性语言障碍病例]
Rinsho Shinkeigaku. 2023 Oct 25;63(10):650-655. doi: 10.5692/clinicalneurol.cn-001852. Epub 2023 Sep 30.
10
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.一名非洲患者中与转甲状腺素蛋白Leu12Pro相关的眼软脑膜淀粉样变性
J Neurol. 2015 Jan;262(1):228-34. doi: 10.1007/s00415-014-7594-2. Epub 2014 Dec 9.

引用本文的文献

1
Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review.遗传性转甲状腺素蛋白淀粉样变性的认知表现与脑完整性:一项系统综述
J Neurol. 2025 May 25;272(6):419. doi: 10.1007/s00415-025-13120-1.
2
Liver-directed drugs for transthyretin-mediated amyloidosis.针对转甲状腺素蛋白介导淀粉样变性的肝靶向药物。
J Peripher Nerv Syst. 2022 Dec;27(4):228-237. doi: 10.1111/jns.12519. Epub 2022 Nov 16.

本文引用的文献

1
CNS Involvement in Hereditary Transthyretin Amyloidosis.中枢神经系统受累的遗传性转甲状腺素蛋白淀粉样变性。
Neurology. 2021 Dec 14;97(24):1111-1119. doi: 10.1212/WNL.0000000000012965. Epub 2021 Oct 18.
2
Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.当前对转甲状腺素蛋白突变相关脑脊髓液淀粉样变性的综述。
Neurologist. 2021 Sep 7;26(5):189-195. doi: 10.1097/NRL.0000000000000337.
3
Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation.一名年轻的非裔加勒比女性因Thr60Ala突变导致甲状腺素运载蛋白淀粉样变性病的早发情况。
JACC Case Rep. 2020 Nov 4;2(13):2063-2067. doi: 10.1016/j.jaccas.2020.08.030. eCollection 2020 Nov.
4
Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.托卡朋,一种有效的聚集抑制剂,用于治疗家族性脑脊髓液淀粉样变性病。
FEBS J. 2021 Jan;288(1):310-324. doi: 10.1111/febs.15339. Epub 2020 May 11.
5
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.遗传性转甲状腺素蛋白淀粉样变性病:致命疾病的医学进步典范。
Nat Rev Neurol. 2019 Jul;15(7):387-404. doi: 10.1038/s41582-019-0210-4. Epub 2019 Jun 17.
6
Transthyretin stabilization activity of the catechol--methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study.儿茶酚--O-甲基转移酶抑制剂托卡朋(SOM0226)稳定转甲状腺素蛋白在遗传性ATTR 淀粉样变性患者和无症状携带者中的活性:概念验证研究。
Amyloid. 2019 Jun;26(2):74-84. doi: 10.1080/13506129.2019.1597702. Epub 2019 May 23.
7
Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.遗传性转甲状腺素淀粉样变性病 ATTRV30M 有效治疗时代的眼睛中转甲状腺素沉积。
Amyloid. 2019 Mar;26(1):10-14. doi: 10.1080/13506129.2018.1554563. Epub 2019 Jan 24.
8
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
9
Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.遗传性 ATTRV30M(p.TTRV50M)淀粉样变性患者口服塔法米迪治疗时脑脊液和玻璃体中的暴露情况。
Amyloid. 2018 Jun;25(2):120-128. doi: 10.1080/13506129.2018.1479249. Epub 2018 Jul 11.
10
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.依洛瑟那治疗遗传性转甲状腺素蛋白淀粉样变性病患者。
N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.